Glenmark Pharmaceuticals Limited (NSE:GLENMARK)

India · Delayed Price · Currency is INR

2,089.00

-91.10 (-4.18%)

At close: Mar 23, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	133.63B	126.45B	116.56B	123.05B	109.44B
Pharmaceuticals Growth	5.68%	8.49%	-5.28%	12.44%	2.69%
Total	133.63B	126.45B	116.56B	123.05B	109.44B
Total Growth	5.68%	8.49%	-5.28%	12.44%	2.69%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	44.84B	33.97B	40.46B	43.81B	39.53B
India Growth	32.02%	-16.05%	-7.64%	10.83%	8.43%
North America	30.17B	30.94B	31.48B	32.04B	32.04B
North America Growth	-2.49%	-1.71%	-1.73%	-0.02%	-2.46%
Europe	30.06B	25.56B	20.06B	20.05B	16.91B
Europe Growth	17.64%	27.42%	0.04%	18.54%	10.17%
Latin America and Rest of The World	28.14B	27.67B	23.83B	-	-
Latin America and Rest of The World Growth	1.71%	16.07%	-	-	-
Latin America	-	-	-	6.13B	5.66B
Latin America Growth	-	-	-	8.23%	-11.62%
Rest of The World (ROW)	-	-	-	21.03B	15.30B
Rest of The World (ROW) Growth	-	-	-	37.48%	-0.34%
Total	133.22B	118.13B	115.83B	123.05B	109.44B
Total Growth	12.77%	1.98%	-5.86%	12.44%	2.85%

Source: S&P Global Market Intelligence.